Global Male Infertility Market 2023-2030

Global Male Infertility Market 2023-2030

MARKET OUTLOOK

Based on Triton’s research report, the global male infertility market is estimated to progress in revenue at a CAGR of 4.81% during the forecast period 2023-2030.

Factors such as the growing adoption of assisted reproductive technologies and technological innovations fuel the male infertility market’s growth. Additionally, the rising acceptance of minimally invasive surgeries opens new avenues for the studied market. Another notable trend expected to widen the market scope is the increasing government reimbursement policies.

However, the high cost of treatment is anticipated to hamper the expansion of the male infertility market over the forecast period.

REGIONAL OUTLOOK

The global male infertility market encompasses Asia-Pacific, North America, Latin America, Europe, and the Middle East and Africa regions.

Globally, the Asia-Pacific is anticipated to emerge as the fastest-growing region during the forecast period. The region’s growth can be attributed to rising disposable income and collaboration among key players. Another trend that is expected to fuel the demand for infertility treatment is technological advancements, including microfluidic sperm function assays. In addition to these factors, the launch of fertility clinics is expected to further boost the Asia-Pacific male infertility market growth during the forecast period.

COMPETITIVE OUTLOOK

Notable companies in the male infertility market are Halotech DNA, EMD Serono Inc, Endo International Plc, Vitrolife, Bayer AG, Aytu BioPharma, Zydus Lifesciences Limited, CinnaGen Co, Sanofi SA, and Laboratory Corporation of America Holdings.

Sanofi SA develops and markets therapeutic products. Its business segments include specialty care, vaccines, and general medicines. The Sanofi Pasteur company, a major supplier of vaccines, serves as the main operating platform for the vaccines business unit. Consumer Healthcare (CHC) is another division, a stand-alone business unit with integrated R&D, manufacturing, service, and IT capabilities. Sanofi has operations across more than 90 countries, with headquarters in Paris, France.